Comparison of insulin analogue regimens in people with type 2 diabetes mellitus in the PREFER Study: a randomized controlled trial.
about
Efficacy and safety of biphasic insulin aspart and biphasic insulin lispro mix in patients with type 2 diabetes: A review of the literatureInsulin initiation in patients with type 2 diabetes mellitus: treatment guidelines, clinical evidence and patterns of use of basal vs premixed insulin analoguesUsing insulin in type 2 diabetes: in need of a renaissance?Common standards of basal insulin titration in type 2 diabetesInitiation and Intensification Strategies in Type 2 Diabetes Management: A Comparison of Basal Plus and Premix RegimensSafety and efficacy of insulin glargine 300 u/mL compared with other basal insulin therapies in patients with type 2 diabetes mellitus: a network meta-analysisHypoglycemia Event Rates: A Comparison Between Real-World Data and Randomized Controlled Trial Populations in Insulin-Treated Diabetes.Evidence-based clinical use of insulin premixturesDistinct Prandial and Basal Glucose-Lowering Effects of Insulin Degludec/Insulin Aspart (IDegAsp) at Steady State in Subjects with Type 1 Diabetes MellitusRelationship of baseline HbA1c, HbA1c change and HbA1c target of < 7% with insulin analogues in type 2 diabetes: a meta-analysis of randomised controlled trials.An update on the treatment of type 1 and type 2 diabetes mellitus: focus on insulin detemir, a long-acting human insulin analog.Efficacy of insulin analogs in achieving the hemoglobin A1c target of <7% in type 2 diabetes: meta-analysis of randomized controlled trials.Treat-to-target trials: uses, interpretation and review of concepts.Biphasic insulin aspart 30/70 (BIAsp 30) in the treatment of type 1 and type 2 diabetes.Diabetes: glycaemic control in type 2 (drug treatments).Role of premixed insulin analogues in the treatment of patients with type 2 diabetes mellitus: a narrative reviewComparative Efficacy of Adding Sitagliptin to Metformin, Sulfonylurea or Dual Therapy: A Propensity Score-Weighted Cohort Study.Adherence to insulin treatment in insulin-naïve type 2 diabetic patients initiated on different insulin regimens.Biphasic insulin Aspart 30 vs. NPH plus regular human insulin in type 2 diabetes patients; a cost-effectiveness studyPractical Guidance on the Use of Premix Insulin Analogs in Initiating, Intensifying, or Switching Insulin Regimens in Type 2 DiabetesClinical Outcomes After Insulin Initiation in Patients with Type 2 Diabetes: 24-Month Results from INSTIGATE.Effects of biphasic, basal-bolus or basal insulin analogue treatments on carotid intima-media thickness in patients with type 2 diabetes mellitus: the randomised Copenhagen Insulin and Metformin Therapy (CIMT) trial.Safety and effectiveness of biphasic insulin aspart 30/70 (NovoMix 30) when switching from human premix insulin in patients with type 2 diabetes: subgroup analysis from the 6-month IMPROVE observational study.Intensification to biphasic insulin aspart 30/70 (BIAsp 30, NovoMix 30) can improve glycaemic control in patients treated with basal insulins: a subgroup analysis of the IMPROVE observational study.Practical guidance on intensification of insulin therapy with BIAsp 30: a consensus statement.Safety and effectiveness of biphasic insulin aspart 30 in different age-groups: a1chieve sub-analysis.Biphasic insulin aspart in the treatment of type 2 diabetes mellitus.Treat-to-target trials in diabetes.Increase of body weight during the first year of intensive insulin treatment in type 2 diabetes: systematic review and meta-analysis.Control of postprandial glucose levels with insulin in type 2 diabetes.The economic and clinical benefits of adequate insulin initiation and intensification in people with type 2 diabetes mellitus.Intensifying treatment of type 2 diabetes mellitus: adding insulin.Metabolic control and risk of hypoglycaemia during the first year of intensive insulin treatment in type 2 diabetes: systematic review and meta-analysis.Current insulin analogues in the treatment of diabetes: emphasis on type 2 diabetes.Intensifying insulin treatment: options, practical issues, and the role of the nurse practitioner.Ten years of experience with biphasic insulin aspart 30: from drug development to the latest clinical findings.Insulin detemir: a review of its use in the management of diabetes mellitus.Methods to enhance delivery of prandial insulin and basal-prandial insulin.Biphasic vs basal bolus insulin regimen in Type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.Pharmacologic treatment of type 2 diabetes: injectable medications.
P2860
Q26749095-5C9A2D03-E369-467C-A293-13EFCEDA2678Q26861313-63AD20E6-36D1-4354-8112-A071A45C0247Q26863277-7ED28C82-70DC-4131-8465-1D6495E2D451Q27009355-411B6CF1-D4AD-4EAA-9224-17A1DE614221Q28077688-D9B30B24-6C22-4DAD-9CBC-1C133822222BQ28078467-E224996E-4BA1-45FD-89A2-17C627B3D9A2Q31046934-AAE5769F-B2AF-4835-AD31-F35BADBC9A72Q33591271-64495040-E75E-407B-A852-70951BF04315Q33785190-5871A9BC-74AA-4F09-8BA4-DF282C7FC51EQ33871459-38F53151-BA86-40E2-9108-593F8DD01C68Q33902616-AE654DF2-2038-496C-ACAD-E07CC80494B7Q34507342-E5B252F4-6C54-4BA3-91D6-50FA774A9FA6Q34540987-E416E7C4-C930-4A4E-AC9C-368A29154DF4Q34620736-5860F5D7-572E-43BA-8D76-8219279C354BQ34829290-8341E5EB-B18C-415D-B092-B811CD39E8E1Q34851203-35788F6E-927C-4B72-89A5-0CADAA12314DQ35772558-A1999CE8-30D3-4FBD-9442-1F3086DBAB89Q36015855-EADC4B6F-3338-4909-B2B0-ABA924003DACQ36045779-6CE8C1C4-FCFF-4C56-8563-0E949ECFF326Q36073434-13516E93-027D-4E4F-8B2A-ECC0753BC101Q36428057-62A9AA70-D77C-4FBD-9750-C7395A0EC124Q36633079-9E52E142-F14E-4BED-AED5-9E442300DFC1Q37250601-FCBAFCCD-CB49-4771-8B35-AB1E318E4E1CQ37325832-9180A221-1872-486C-882E-A095E2FF8E93Q37428579-1D1247BF-C1A7-4D3F-A4CE-9AB00686C30AQ37468401-107C4630-7921-4DEA-892D-7981876101BBQ37636162-B612205A-E401-47CE-AA7F-1AA0093C1F78Q37703688-3CBB2746-E39B-4504-AFB2-82EFDD83829FQ37885450-1688F4EE-C98F-43C6-A53B-7074B706ED36Q37890790-20B635E0-167F-4864-8797-688B9FDFB2C2Q37915625-F2A83FF7-CAD2-4359-8742-26E7D7DAA908Q37961849-30B96D5A-B71C-41BA-9F8A-275E840CB3F3Q37964744-C83FB8D7-32FC-467F-923A-136C66AEF2D9Q37972941-70AD8E97-0B07-4F3D-B43C-A5BB77510FBBQ38008006-751C481C-3932-4673-8E6E-949F49BA5C9CQ38028009-273A3F3A-4B71-4672-816E-BB454C1C0DC1Q38056540-6D64E9B2-6632-43F2-88C6-076BB028C336Q38085333-392F8FB1-A46C-4930-AFE1-306DE43DBC4EQ38320545-69B1AD14-4CB3-4F06-A5A2-9CA62E13ED19Q38388602-E6C87B7D-F7E5-4723-914C-745D27E9D2FB
P2860
Comparison of insulin analogue regimens in people with type 2 diabetes mellitus in the PREFER Study: a randomized controlled trial.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Comparison of insulin analogue ...... a randomized controlled trial.
@en
Comparison of insulin analogue ...... a randomized controlled trial.
@nl
type
label
Comparison of insulin analogue ...... a randomized controlled trial.
@en
Comparison of insulin analogue ...... a randomized controlled trial.
@nl
prefLabel
Comparison of insulin analogue ...... a randomized controlled trial.
@en
Comparison of insulin analogue ...... a randomized controlled trial.
@nl
P2093
P1476
Comparison of insulin analogue ...... a randomized controlled trial.
@en
P2093
B Gallwitz
PREFER Study Group
R Bergenstal
P356
10.1111/J.1463-1326.2008.00915.X
P577
2008-07-17T00:00:00Z